Latest News about AMGN
Recent news which mentions AMGN
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 11, 2022
October 11, 2022
From Benzinga
Apple To $155? Plus Morgan Stanley Cuts Price Target On Zoom Video
October 11, 2022
From Benzinga
US Buys $290M Anti-Radiation Drugs After Putin Ups Nuclear Threats
October 09, 2022
Tickers
AMGN
From Benzinga
7 Value Stocks That Are Too Cheap to Ignore
October 09, 2022
From InvestorPlace
2 Healthcare Stocks That Could Help Make You a Fortune
October 08, 2022
From Motley Fool
$100 Invested In This Stock 15 Years Ago Would Be Worth $400 Today
October 06, 2022
Tickers
AMGN
From Benzinga
The Short List Of Dow Jones Stocks That Are Actually Up This Year: Hint — It's Very Short
October 03, 2022
From Benzinga
Could This Biosimilar Drug Candidate Be a Hit for Novartis?
October 03, 2022
From Motley Fool
3 Biotech Stocks to Buy and Hold for the Next 10 Years
September 28, 2022
From Motley Fool
Warning! A Housing Market Crash Will Tank These 3 Stocks.
September 27, 2022
From InvestorPlace
The 7 Best Stocks to Buy to Tap Into a Hidden Bull Market
September 27, 2022
From InvestorPlace
From Benzinga
$100 Invested In This Stock 15 Years Ago Would Be Worth $400 Today
September 21, 2022
Tickers
AMGN
From Benzinga
Take-Two Gets Beat Down After Leak of Its Popular Grand Theft Auto VI
September 19, 2022
From Benzinga
Top US Drugmakers Exploit US Patent System To Keep Generic Competition At Bay: Report
September 16, 2022
From Benzinga
Amgen’s new cancer drug faces questions about competition
September 15, 2022
From MarketWatch
US Department Of Health, Defense To Inject $1B To Boost Domestic Biomanufacturing
September 14, 2022
From Benzinga
From Motley Fool
Biden Administration Pushes 'Cancer Moonshot' Initiative: Report
September 13, 2022
From Benzinga
Livent, Amgen And Some Other Big Stocks Moving Lower On Monday
September 12, 2022
From Benzinga
From InvestorPlace
Here's Why Amgen Shares Are Diving
September 12, 2022
From Benzinga
From Benzinga
3 Stocks Expecting Good News From the FDA
September 12, 2022
From Motley Fool
Amgen's Lumakras Cuts Risk Of Progression By 34% In KRAS-Mutated Lung Cancer Patients
September 12, 2022
Tickers
AMGN
From Benzinga
Bristol Myers' Deucravacitinib Scores FDA Approval For Plaque Psoriasis
September 12, 2022
From Benzinga
Could This Biosimilar Drug Candidate Be a Winner for Amgen?
September 09, 2022
From Motley Fool
7 Dow Stocks With Superior Fundamentals
September 06, 2022
From InvestorPlace
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.